Detalhe da pesquisa
1.
Efficacy and tolerability of VCD chemotherapy in a UK real-world dataset of elderly transplant-ineligible newly diagnosed myeloma patients.
Eur J Haematol
; 106(4): 563-573, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33496996
2.
Long term outcomes in monoclonal gammopathy of renal significance.
Br J Haematol
; 186(5): 706-716, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31141168
3.
Carfilzomib therapy for relapsed myeloma: results of a UK multicentre experience.
Br J Haematol
; 188(4): e57-e60, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31792927
4.
Infection-related morbidity in a large study of transplant non-eligible newly diagnosed myeloma patients treated with UK standard of care.
Haematologica
; 105(9): e474-479, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054067
5.
Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients.
PLoS One
; 17(1): e0262388, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35015781
6.
Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma.
Clin Cancer Res
; 28(13): 2854-2864, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35522533
7.
Pathophysiology and management of monoclonal gammopathy of renal significance.
Blood Adv
; 3(15): 2409-2423, 2019 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409583